GERN
GERON CORP
Company overview
- Market capitalization
- $803.09M
- Employees
- 258
- Latest publication
- 2026-09-29
About GERON CORP
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20242024-12-31 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD | Q3 20232023-09-30 · USD | Q1 20232023-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 57,480,000USD | 51,837,000USD | 47,537,000USD | 882,000USD | 304,000USD | 23,000USD | 164,000USD | 21,000USD |
| Selling General Administrative | 38,863,000USD | 35,425,000USD | 43,371,000USD | 39,419,000USD | 27,065,000USD | 21,401,000USD | 18,350,000USD | 12,894,000USD |
| Total Operating Expenses | 69,976,000USD | 50,381,000USD | 66,804,000USD | 70,198,000USD | 56,438,000USD | 54,312,000USD | 47,776,000USD | 40,113,000USD |
| Operating Income | -12,496,000USD | -236,000USD | -20,050,000USD | -69,333,000USD | -56,134,000USD | -54,289,000USD | -47,612,000USD | -40,092,000USD |
| Total Other Income Expense Net | -9,000USD | -3,406,000USD | -5,302,000USD | 1,950,000USD | 744,000USD | 2,316,000USD | 2,807,000USD | 1,970,000USD |
| Interest Income | 2,971,000USD | 3,421,000USD | 5,159,000USD | 5,332,000USD | 4,239,000USD | 4,596,000USD | 4,965,000USD | 3,853,000USD |
| Interest Expense | 7,146,000USD | 7,147,000USD | 8,706,000USD | 3,319,000USD | 3,433,000USD | 2,321,000USD | 2,066,000USD | 1,922,000USD |
| Net Income | -16,680,000USD | -3,642,000USD | -25,352,000USD | -67,383,000USD | -55,390,000USD | -51,973,000USD | -44,805,000USD | -38,122,000USD |
| Cost Of Revenue | — | 1,692,000USD | 783,000USD | 17,000USD | 275,000USD | 241,000USD | 29,426,000USD | 251,000USD |
| Gross Profit | — | 50,145,000USD | 46,754,000USD | 865,000USD | 304,000USD | 23,000USD | 164,000USD | 21,000USD |
| Research Development | — | 14,956,000USD | 23,433,000USD | 30,779,000USD | 29,373,000USD | 32,911,000USD | 29,426,000USD | 27,219,000USD |
| Net Interest Income | — | -3,726,000USD | -3,547,000USD | 2,013,000USD | 806,000USD | 2,275,000USD | 2,899,000USD | 1,931,000USD |
| Income Before Tax | — | -3,642,000USD | -25,352,000USD | -67,383,000USD | -55,390,000USD | -51,973,000USD | -44,805,000USD | -38,122,000USD |
| Net Income From Continuing Ops | — | -3,642,000USD | -25,352,000USD | -67,383,000USD | -55,390,000USD | -51,973,000USD | -44,805,000USD | -38,122,000USD |
| Ebit | — | 3,505,000USD | -16,646,000USD | -64,064,000USD | -51,957,000USD | -49,652,000USD | -42,739,000USD | -36,200,000USD |
| Ebitda | — | 3,831,000USD | -16,330,000USD | -63,635,000USD | -51,682,000USD | -49,411,000USD | -42,473,000USD | -35,949,000USD |
| Depreciation And Amortization | — | 326,000USD | 316,000USD | 429,000USD | 275,000USD | 241,000USD | 266,000USD | 251,000USD |
| Reconciled Depreciation | — | 326,000USD | 316,000USD | 429,000USD | 275,000USD | 241,000USD | 266,000USD | 251,000USD |
| Selling And Marketing Expenses | — | — | — | 429,000USD | 275,000USD | 241,000USD | — | — |
| Income Tax Expense | — | — | — | — | 231,724USD | 197,188USD | -266,000USD | -48,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | -44,805,000USD | -38,122,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 3,892,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20192019-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 76,994,000USD | 237,000USD | 596,000USD | 460,000USD | 36,371,000USD | 1,153,000USD | 1,283,000USD | 2,709,000USD |
| Cost Of Revenue | 1,256,000USD | 123,740,000USD | 868,000USD | 39,263,000USD | 9,574,000USD | 8,901,000USD | 9,134,000USD | 25,178,000USD |
| Gross Profit | 75,738,000USD | 237,000USD | 596,000USD | 460,000USD | 26,797,000USD | -7,748,000USD | -7,851,000USD | -22,469,000USD |
| Research Development | 103,738,000USD | 125,046,000USD | 95,518,000USD | 52,072,000USD | 17,831,000USD | 20,707,000USD | 23,155,000USD | 51,368,000USD |
| Selling General Administrative | 145,732,000USD | 69,135,000USD | 43,628,000USD | 20,893,000USD | 17,793,000USD | 16,758,000USD | 15,624,000USD | 20,397,000USD |
| Total Operating Expenses | 249,470,000USD | 194,181,000USD | 139,146,000USD | 72,965,000USD | 35,624,000USD | 37,465,000USD | 38,779,000USD | 71,765,000USD |
| Operating Income | -173,732,000USD | -193,944,000USD | -138,550,000USD | -72,505,000USD | -559,000USD | -36,312,000USD | -38,958,000USD | -71,758,000USD |
| Interest Income | 19,607,000USD | 18,152,000USD | 2,529,000USD | 4,221,000USD | 605,000USD | — | — | — |
| Interest Expense | 18,504,000USD | 8,312,000USD | 6,882,000USD | 0USD | 88,000USD | 82,000USD | 56,000USD | 233,000USD |
| Net Interest Income | 1,103,000USD | 9,840,000USD | -4,353,000USD | 4,221,000USD | — | — | — | — |
| Income Before Tax | -174,572,000USD | -184,127,000USD | -141,901,000USD | -68,548,000USD | 46,000USD | -35,670,000USD | -38,379,000USD | -68,881,000USD |
| Net Income | -174,572,000USD | -184,127,000USD | -141,901,000USD | -63,551,000USD | 46,000USD | -35,670,000USD | -38,379,000USD | -68,881,000USD |
| Net Income From Continuing Ops | -174,572,000USD | -184,127,000USD | -141,901,000USD | -68,353,000USD | 46,000USD | -35,670,000USD | -38,379,000USD | -68,881,000USD |
| Ebit | -156,068,000USD | -175,815,000USD | -135,019,000USD | -72,505,000USD | 747,000USD | -35,670,000USD | -38,379,000USD | -68,648,000USD |
| Ebitda | -154,847,000USD | -174,782,000USD | -134,151,000USD | -71,729,000USD | 803,000USD | -35,623,000USD | -38,059,000USD | -67,818,000USD |
| Depreciation And Amortization | 1,221,000USD | 1,033,000USD | 868,000USD | 776,000USD | 56,000USD | 47,000USD | 320,000USD | 830,000USD |
| Reconciled Depreciation | 1,221,000USD | 1,033,000USD | 868,000USD | 776,000USD | — | — | — | — |
| Total Other Income Expense Net | -840,000USD | 9,817,000USD | -3,351,000USD | 3,957,000USD | 605,000USD | 642,000USD | 579,000USD | 2,877,000USD |
| Selling And Marketing Expenses | — | 1,033,000USD | — | 800,000USD | — | — | — | — |
| Income Tax Expense | — | 1USD | -868,000USD | -4,997,000USD | 32,000USD | 35,000USD | 56,000USD | -597,000USD |
| Non Operating Income Net Other | — | — | 3,531,000USD | 4,152,000USD | 605,000USD | 642,000USD | 579,000USD | 2,877,000USD |
| Net Income Applicable To Common Shares | — | — | -141,901,000USD | -68,548,000USD | 46,000USD | -35,670,000USD | -38,379,000USD | -68,881,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 519,009,000USD | 534,120,000USD | 570,540,000USD | 567,382,000USD | 555,198,000USD | 562,450,000USD | 593,781,000USD | 444,950,000USD |
| Cash And Equivalents | 62,643,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 486,339,000USD | 498,531,000USD | 520,270,999USD | 522,342,000USD | 505,595,000USD | 495,769,000USD | 490,992,000USD | 398,057,000USD |
| Other Current Assets | 6,495,000USD | 140,151,000USD | 121,245,999USD | 11,027,000USD | 9,126,000USD | 8,687,000USD | 6,913,000USD | 7,911,000USD |
| Total Liabilities | 300,395,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 70,331,000USD | 73,570,000USD | 111,542,000USD | 87,712,000USD | 64,283,000USD | 63,034,000USD | 88,298,000USD | 137,933,000USD |
| Other Current Liabilities | 30,715,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 218,614,000USD | 229,108,000USD | 225,872,000USD | 248,707,000USD | 259,531,000USD | 268,238,000USD | 280,320,000USD | 292,284,000USD |
| Total Equity Including Noncontrolling Interest | 218,614,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 120,131,000USD | 119,833,000USD | 119,547,000USD | 119,264,000USD | 118,991,000USD | 118,728,000USD | 118,476,000USD | 12,275,000USD |
| Net Receivables | 51,640,000USD | 44,095,000USD | 39,226,000USD | 35,361,000USD | 39,363,000USD | 33,983,000USD | 38,799,000USD | 30,089,000USD |
| Inventory | 123,604,000USD | 133,287,000USD | 116,636,000USD | 95,422,000USD | 69,125,000USD | 56,222,000USD | 38,714,000USD | 20,283,000USD |
| Property Plant Equipment Net | 2,852,000USD | 1,000,000USD | 884,000USD | 3,312,000USD | 3,712,000USD | 3,851,000USD | 4,191,000USD | 4,650,000USD |
| Accounts Payable | 8,805,000USD | 12,720,000USD | 11,257,000USD | 11,111,000USD | 8,226,000USD | 8,032,000USD | 8,595,000USD | 13,734,000USD |
| Short Term Debt | 1,013,000USD | 20,397,000USD | 19,448,000USD | 994,000USD | 987,000USD | 981,000USD | 974,000USD | 72,530,000USD |
| Common Stock | 642,000USD | 641,000USD | 640,000USD | 638,000USD | 638,000USD | 637,000USD | 606,000USD | 603,000USD |
| Retained Earnings | -1,876,163,000USD | -1,859,483,000USD | -1,855,841,000USD | -1,826,979,000USD | -1,808,551,000USD | -1,792,176,000USD | -1,772,341,000USD | -1,746,989,000USD |
| Accumulated Other Comprehensive Income | -339,000USD | -191,000USD | 269,000USD | 408,000USD | 117,000USD | 304,000USD | 261,000USD | 1,017,000USD |
| Total Liab | — | 305,012,000USD | 344,668,000USD | 318,675,000USD | 295,667,000USD | 294,212,000USD | 313,461,000USD | 152,666,000USD |
| Other Current Liab | — | 40,453,000USD | 80,837,000USD | 75,607,000USD | 55,070,000USD | 53,140,000USD | 78,729,000USD | 51,669,000USD |
| Capital Stock | — | 641,000USD | 640,000USD | 638,000USD | 638,000USD | 637,000USD | 606,000USD | 603,000USD |
| Cash | — | 70,779,000USD | 79,440,000USD | 78,117,000USD | 77,734,000USD | 83,745,000USD | 79,016,000USD | 60,344,000USD |
| Cash And Short Term Investments | — | 314,285,000USD | 359,799,000USD | 380,532,000USD | 387,981,000USD | 396,877,000USD | 406,566,000USD | 339,774,000USD |
| Net Debt | — | 181,060,000USD | 172,134,000USD | 43,799,000USD | 44,109,000USD | 38,033,000USD | 42,700,000USD | 26,919,000USD |
| Short Long Term Debt Total | — | 251,839,000USD | 251,574,000USD | 121,916,000USD | 121,843,000USD | 121,778,000USD | 121,716,000USD | 87,263,000USD |
| Long Term Investments | — | 26,686,000USD | 41,289,000USD | 39,063,000USD | 42,743,000USD | 58,795,000USD | 94,519,000USD | 37,312,000USD |
| Short Term Investments | — | 243,506,000USD | 280,359,000USD | 302,415,000USD | 310,247,000USD | 313,132,000USD | 327,550,000USD | 279,430,000USD |
| Property Plant Equipment Gross | — | 2,959,000USD | 5,239,000USD | 3,312,000USD | 3,712,000USD | 3,851,000USD | 5,888,000USD | 4,650,000USD |
| Common Stock Shares Outstanding | — | 669,375,000shares | 667,164,851shares | 667,101,756shares | 666,170,358shares | 665,905,000shares | 646,033,000shares | 662,158,000shares |
| Non Current Assets Total | — | 35,589,000USD | 50,269,000USD | 45,040,000USD | 49,603,000USD | 66,681,000USD | 102,789,000USD | 46,893,000USD |
| Non Current Liabilities Total | — | 231,442,000USD | 233,125,999USD | 230,963,000USD | 231,384,000USD | 231,178,000USD | 225,163,000USD | 14,733,000USD |
| Non Current Liabilities Other | — | 110,383,000USD | 112,134,000USD | 110,041,000USD | 110,528,000USD | 110,381,000USD | 104,421,000USD | — |
| Non Currrent Assets Other | — | 7,903,000USD | 8,096,000USD | 2,665,000USD | 3,148,000USD | 4,035,000USD | 4,079,000USD | 4,931,000USD |
| Net Working Capital | — | 424,961,000USD | 408,729,000USD | 434,630,000USD | 441,312,000USD | 432,735,000USD | 402,694,000USD | 260,124,000USD |
| Unclassified Current Assets | — | -133,287,000USD | -116,636,000USD | — | — | — | — | — |
| Unclassified Equity | — | 2,087,500,000USD | 2,080,164,000USD | 2,074,002,000USD | 2,066,689,000USD | 2,058,836,000USD | 2,051,188,000USD | 2,037,050,000USD |
| Current Deferred Revenue | — | — | — | — | — | 881,000USD | — | — |
| Other Assets | — | — | — | — | — | — | -682,000USD | — |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | 2,266,000USD | 2,458,000USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 71,562,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -71,562,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 570,540,000USD | 593,781,000USD | 394,076,000USD | 190,575,000USD | 226,034,000USD | 270,728,000USD | 165,517,000USD | 185,284,000USD |
| Other Current Assets | 121,245,999USD | 6,913,000USD | 5,994,000USD | 4,356,000USD | 1,721,000USD | 2,860,000USD | 1,481,000USD | 1,601,000USD |
| Total Liab | 344,668,000USD | 313,461,000USD | 146,127,000USD | 110,577,000USD | 99,618,000USD | 59,781,000USD | 30,362,000USD | 7,551,000USD |
| Total Stockholder Equity | 225,872,000USD | 280,320,000USD | 247,949,000USD | 79,998,000USD | 126,416,000USD | 210,947,000USD | 135,155,000USD | 177,733,000USD |
| Other Current Liab | 80,837,000USD | 78,729,000USD | 54,067,000USD | 44,634,000USD | 37,933,000USD | 23,143,000USD | 26,627,000USD | 6,569,000USD |
| Common Stock | 640,000USD | 606,000USD | 545,000USD | 390,000USD | 324,000USD | 310,000USD | 200,000USD | 186,000USD |
| Capital Stock | 640,000USD | 606,000USD | 545,000USD | 390,000USD | 324,000USD | 310,000USD | 200,000USD | 186,000USD |
| Retained Earnings | -1,855,841,000USD | -1,772,341,000USD | -1,597,769,000USD | -1,413,642,000USD | -1,271,741,000USD | -1,155,629,000USD | -1,080,012,000USD | -1,011,464,000USD |
| Cash | 79,440,000USD | 79,016,000USD | 70,023,000USD | 56,845,000USD | 34,871,000USD | 9,925,000USD | 13,644,000USD | 10,844,000USD |
| Cash And Short Term Investments | 359,799,000USD | 406,566,000USD | 333,699,000USD | 172,746,000USD | 183,722,000USD | 196,275,000USD | 139,325,000USD | 163,558,000USD |
| Total Current Assets | 520,270,999USD | 490,992,000USD | 341,348,000USD | 180,246,000USD | 187,206,000USD | 199,857,000USD | 141,608,000USD | 166,058,000USD |
| Total Current Liabilities | 111,542,000USD | 88,298,000USD | 108,070,000USD | 76,694,000USD | 45,521,000USD | 30,940,000USD | 28,162,000USD | 7,551,000USD |
| Net Debt | 172,134,000USD | 42,700,000USD | 15,876,000USD | -1,092,000USD | 20,127,000USD | 19,794,000USD | -11,090,000USD | -10,844,000USD |
| Short Term Debt | 19,448,000USD | 974,000USD | 47,842,000USD | 21,870,000USD | 901,000USD | 878,000USD | 354,000USD | — |
| Short Long Term Debt Total | 251,574,000USD | 121,716,000USD | 85,899,000USD | 55,753,000USD | 54,998,000USD | 29,719,000USD | 2,554,000USD | — |
| Long Term Debt | 119,547,000USD | 118,476,000USD | 35,051,000USD | 30,212,000USD | 49,830,000USD | 24,042,000USD | — | — |
| Long Term Investments | 41,289,000USD | 94,519,000USD | 43,298,000USD | 0USD | 28,651,000USD | 63,387,000USD | 19,651,000USD | 18,582,000USD |
| Short Term Investments | 280,359,000USD | 327,550,000USD | 263,676,000USD | 115,901,000USD | 148,851,000USD | 186,350,000USD | 125,681,000USD | 152,714,000USD |
| Net Receivables | 39,226,000USD | 38,799,000USD | 1,655,000USD | 3,144,000USD | 1,763,000USD | 722,000USD | 802,000USD | 1,168,000USD |
| Inventory | 116,636,000USD | 38,714,000USD | 0USD | -3,144,000USD | -1,399,000USD | -722,000USD | -802,000USD | -1,168,000USD |
| Accounts Payable | 11,257,000USD | 8,595,000USD | 6,161,000USD | 10,190,000USD | 6,687,000USD | 6,919,000USD | 1,181,000USD | 982,000USD |
| Property Plant Equipment Net | 884,000USD | 4,191,000USD | 4,733,000USD | 4,940,000USD | 5,377,000USD | 5,953,000USD | 2,905,000USD | 59,000USD |
| Property Plant Equipment Gross | 5,239,000USD | 5,888,000USD | 5,964,000USD | 793,000USD | 6,027,000USD | 5,953,000USD | 2,905,000USD | 59,000USD |
| Accumulated Other Comprehensive Income | 269,000USD | 261,000USD | 185,000USD | -219,000USD | -173,000USD | 78,000USD | 132,000USD | -183,000USD |
| Common Stock Shares Outstanding | 666,662,989shares | 646,033,000shares | 570,645,405shares | 380,784,846shares | 327,631,814shares | 271,460,265shares | 190,160,311shares | 176,504,996shares |
| Non Current Assets Total | 50,269,000USD | 102,789,000USD | 52,728,000USD | 10,329,000USD | 38,828,000USD | 70,871,000USD | 23,909,000USD | 19,226,000USD |
| Non Current Liabilities Total | 233,125,999USD | 225,163,000USD | 38,057,000USD | 33,883,000USD | 54,097,000USD | 28,841,000USD | 2,200,000USD | 0USD |
| Non Current Liabilities Other | 112,134,000USD | 104,421,000USD | — | 3,671,000USD | 4,267,000USD | 4,799,000USD | — | — |
| Non Currrent Assets Other | 8,096,000USD | 4,079,000USD | 4,697,000USD | 5,389,000USD | 4,800,000USD | 1,531,000USD | 1,353,000USD | 585,000USD |
| Net Working Capital | 408,729,000USD | 402,694,000USD | 233,278,000USD | 103,552,000USD | 141,685,000USD | 168,917,000USD | 113,446,000USD | 158,507,000USD |
| Unclassified Current Assets | -116,636,000USD | — | — | — | — | — | — | — |
| Unclassified Equity | 2,080,164,000USD | 2,051,188,000USD | 1,844,443,000USD | 1,493,079,000USD | 1,397,682,000USD | 1,365,878,000USD | 1,214,635,000USD | 1,189,008,000USD |
| Other Assets | — | 1USD | — | 5,389,000USD | 4,800,000USD | 1,531,000USD | 964,000USD | 585,000USD |
| Unclassified Non Current Liabilities | — | 2,266,000USD | 3,006,000USD | — | — | — | 2,200,000USD | — |
| Short Long Term Debt | — | — | 46,893,000USD | 20,945,000USD | — | — | — | — |
| Unclassified Current Liabilities | — | — | -46,893,000USD | -20,945,000USD | — | — | — | — |
| Net Tangible Assets | — | — | — | 79,998,000USD | 126,416,000USD | 210,947,000USD | 137,355,000USD | 177,733,000USD |
| Unclassified Non Current Assets | — | — | — | -5,389,000USD | -4,800,000USD | -1,531,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,642,000USD | -28,862,000USD | -18,428,000USD | -16,375,000USD | -19,835,000USD | -25,352,000USD | -26,447,000USD | -67,383,000USD |
| Depreciation | 326,000USD | 275,000USD | 312,000USD | 309,000USD | 308,000USD | 316,000USD | 201,000USD | 429,000USD |
| Stock Based Compensation | 4,913,000USD | 7,426,000USD | 6,771,000USD | -7,382,000USD | 7,423,000USD | 6,806,000USD | 6,905,000USD | 12,640,000USD |
| Other Non Cash Items | -592,000USD | 11,564,000USD | 84,000USD | 14,616,000USD | -707,000USD | -2,789,000USD | -1,986,000USD | -1,836,000USD |
| Change To Account Receivables | -4,894,000USD | -966,000USD | 1,273,000USD | -5,333,000USD | 4,649,000USD | -8,886,000USD | -27,133,000USD | -874,000USD |
| Change To Inventory | -16,651,000USD | -21,214,000USD | -26,298,000USD | -12,902,000USD | -17,508,000USD | -17,688,000USD | -19,509,000USD | -774,000USD |
| Change In Working Capital | -63,911,000USD | -12,470,000USD | -2,315,000USD | -18,583,000USD | -35,168,000USD | -22,926,000USD | -37,615,000USD | 2,672,000USD |
| Total Cash From Operating Activities | -62,906,000USD | -22,067,000USD | -13,576,000USD | -27,415,000USD | -47,979,000USD | -43,945,000USD | -58,942,000USD | -53,478,000USD |
| Capital Expenditures | -252,000USD | -32,000USD | -89,000USD | -138,000USD | -47,979,000USD | -141,000USD | 0USD | -206,000USD |
| Free Cash Flow | -63,158,000USD | -22,099,000USD | -13,487,000USD | -27,553,000USD | -47,979,000USD | -43,804,000USD | -58,942,000USD | -53,684,000USD |
| Investments | 52,108,000USD | 21,145,000USD | 13,348,000USD | 20,315,000USD | 52,439,000USD | -103,511,000USD | -554,000USD | -36,146,000USD |
| Total Cashflows From Investing Activities | 51,856,000USD | 21,145,000USD | 13,348,000USD | 20,315,000USD | 52,439,000USD | -103,511,000USD | -554,000USD | -36,146,000USD |
| Total Cash From Financing Activities | 2,425,000USD | 378,000USD | 542,000USD | 1,091,000USD | 256,000USD | 166,163,000USD | 3,578,000USD | 16,833,000USD |
| Change In Cash | -8,661,000USD | -553,000USD | 389,000USD | -6,006,000USD | 4,734,000USD | 18,678,000USD | -55,870,000USD | -72,812,000USD |
| Begin Period Cash Flow | 79,440,000USD | 79,993,000USD | 79,604,000USD | 85,610,000USD | 80,876,000USD | 62,198,000USD | 118,068,000USD | 190,880,000USD |
| End Period Cash Flow | 70,779,000USD | 79,440,000USD | 79,993,000USD | 79,604,000USD | 85,610,000USD | 80,876,000USD | 62,198,000USD | 118,068,000USD |
| Other Cashflows From Financing Activities | 2,425,000USD | 378,000USD | — | 244,000USD | 256,000USD | 159,566,000USD | 3,578,000USD | 17,104,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | -271,000USD |
| Other Cashflows From Investing Activities | — | 64,000USD | -32,000USD | -32,000USD | 32,000USD | — | 1USD | -35,940,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | 47,947,000USD | — | — | 36,146,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | 6,597,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -85,782,000USD | -174,572,000USD | -184,127,000USD | -141,901,000USD | -116,112,000USD | -75,617,000USD | -27,017,000USD | -27,916,000USD |
| Depreciation | 1,204,000USD | 1,221,000USD | 1,033,000USD | 868,000USD | 783,000USD | 935,000USD | 59,000USD | 76,000USD |
| Stock Based Compensation | 88,000USD | 31,320,000USD | 19,354,000USD | 8,001,000USD | 8,080,000USD | 6,895,000USD | 6,368,000USD | 8,144,000USD |
| Other Non Cash Items | 41,989,000USD | -8,176,000USD | -10,062,000USD | 626,000USD | 984,000USD | 264,000USD | 191,000USD | 200,000USD |
| Change To Account Receivables | -377,000USD | -36,893,000USD | 1,490,000USD | -1,381,000USD | -1,041,000USD | 80,000USD | -528,000USD | 39,000USD |
| Change To Inventory | -77,922,000USD | -37,971,000USD | 0USD | 1,381,000USD | 1,041,000USD | -80,000USD | — | 0USD |
| Change In Working Capital | -68,536,000USD | -68,411,000USD | 6,059,000USD | 5,027,000USD | 10,518,000USD | 383,000USD | -245,000USD | -1,370,000USD |
| Total Cash From Operating Activities | -111,037,000USD | -218,618,000USD | -167,743,000USD | -127,379,000USD | -95,556,000USD | -66,652,000USD | -21,009,000USD | -20,556,000USD |
| Capital Expenditures | -49,000USD | -680,000USD | -830,000USD | -431,000USD | -207,000USD | -401,000USD | -16,000USD | -16,000USD |
| Free Cash Flow | -111,086,000USD | -219,298,000USD | -168,573,000USD | -127,810,000USD | -95,763,000USD | -67,053,000USD | -21,025,000USD | -20,556,000USD |
| Investments | 107,296,000USD | -106,004,000USD | -180,322,000USD | 62,498,000USD | 70,560,000USD | -105,258,000USD | -77,702,000USD | 22,970,000USD |
| Total Cashflows From Investing Activities | 107,247,000USD | -106,004,000USD | -180,322,000USD | 62,067,000USD | 71,947,000USD | -105,320,000USD | -77,718,000USD | 22,970,000USD |
| Net Borrowings | 0USD | 34,566,000USD | 29,700,000USD | 0USD | 24,895,000USD | 23,863,000USD | 23,863,000USD | 23,863,000USD |
| Total Cash From Financing Activities | 2,267,000USD | 334,372,000USD | 362,021,000USD | 87,264,000USD | 48,556,000USD | 168,346,000USD | 92,968,000USD | 1,111,000USD |
| Issuance Of Capital Stock | 0USD | 140,729,000USD | 213,337,000USD | 69,916,000USD | 20,385,000USD | 144,259,000USD | 86,017,000USD | — |
| Change In Cash | -1,436,000USD | 9,738,000USD | 13,929,000USD | 21,974,000USD | 24,947,000USD | -3,626,000USD | -5,759,000USD | 3,525,000USD |
| Begin Period Cash Flow | 80,876,000USD | 71,138,000USD | 57,209,000USD | 35,235,000USD | 10,288,000USD | 13,914,000USD | 16,603,000USD | 12,810,000USD |
| End Period Cash Flow | 79,440,000USD | 80,876,000USD | 71,138,000USD | 57,209,000USD | 35,235,000USD | 10,288,000USD | 10,844,000USD | 16,335,000USD |
| Other Cashflows From Financing Activities | 2,267,000USD | 159,077,000USD | 118,984,000USD | 17,348,000USD | 3,276,000USD | 224,000USD | 6,951,000USD | 51,000USD |
| Other Cashflows From Investing Activities | — | — | -179,492,000USD | 1,233,000USD | -1,594,000USD | -339,000USD | -77,702,000USD | 22,970,000USD |
| Unclassified Investing Cash Flow | — | — | 180,322,000USD | -1,233,000USD | 3,188,000USD | — | 77,702,000USD | -22,954,000USD |
| Change To Liabilities | — | — | — | 10,204,000USD | 14,558,000USD | 16,516,000USD | 127,000USD | 278,000USD |
| Sale Purchase Of Stock | — | — | — | 17,348,000USD | 23,661,000USD | 4,299,000USD | 92,968,000USD | 1,111,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 21,952,000USD | 24,947,000USD | -3,626,000USD | -5,759,000USD | 3,525,000USD |
| Unclassified Financing Cash Flow | — | — | — | 52,568,000USD | -3,276,000USD | 139,960,000USD | -30,814,000USD | -23,914,000USD |
| Dividends Paid | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Chargebacks | -9,190,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Distributor Service Fees | -2,371,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Government Rebates | -1,969,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Revenues Before Adjustments | 72,436,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Royalty | 7,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Sales Returns And Allowance | -1,433,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Chargebacks | -8,164,000 | USD | 0000886744-26-000032 |
| Q1 2026Quarterly · 2026-03-31 | Product | Distributor Service Fees | -2,169,000 | USD | 0000886744-26-000032 |
| Q1 2026Quarterly · 2026-03-31 | Product | Government Rebates | -1,658,000 | USD | 0000886744-26-000032 |
| Q1 2026Quarterly · 2026-03-31 | Product | Revenues Before Adjustments | 65,353,000 | USD | 0000886744-26-000032 |
| Q1 2026Quarterly · 2026-03-31 | Product | Royalty | 66,000 | USD | 0000886744-26-000032 |
| Q1 2026Quarterly · 2026-03-31 | Product | Sales Returns And Allowance | -1,591,000 | USD | 0000886744-26-000032 |
| Q3 2025Quarterly · 2025-09-30 | Product | Chargebacks And Customer Credits | -9,083,000 | USD | 0000886744-25-000071 |
| Q3 2025Quarterly · 2025-09-30 | Product | Government Rebates | -2,143,000 | USD | 0000886744-25-000071 |
| Q3 2025Quarterly · 2025-09-30 | Product | Revenues Before Adjustments | 60,188,000 | USD | 0000886744-25-000071 |
| Q3 2025Quarterly · 2025-09-30 | Product | Royalty | 60,000 | USD | 0000886744-25-000071 |
| Q3 2025Quarterly · 2025-09-30 | Product | Sales Returns And Allowance | -1,795,000 | USD | 0000886744-25-000071 |
| Q2 2025Quarterly · 2025-06-30 | Product | Chargebacks And Customer Credits | -7,890,000 | USD | 0000886744-25-000052 |
| Q2 2025Quarterly · 2025-06-30 | Product | Government Rebates | -459,000 | USD | 0000886744-25-000052 |
| Q2 2025Quarterly · 2025-06-30 | Product | Revenues Before Adjustments | 57,874,000 | USD | 0000886744-25-000052 |
| Q2 2025Quarterly · 2025-06-30 | Product | Royalty | 29,000 | USD | 0000886744-25-000052 |
| Q2 2025Quarterly · 2025-06-30 | Product | Sales Returns And Allowance | -518,000 | USD | 0000886744-25-000052 |
| Q1 2025Quarterly · 2025-03-31 | Product | Chargebacks | -4,171,000 | USD | 0000886744-26-000032 |
| Q1 2025Quarterly · 2025-03-31 | Product | Distributor Service Fees | -1,526,000 | USD | 0000886744-26-000032 |
| Q1 2025Quarterly · 2025-03-31 | Product | Government Rebates | -66,000 | USD | 0000886744-26-000032 |
| Q1 2025Quarterly · 2025-03-31 | Product | Revenues Before Adjustments | 45,312,000 | USD | 0000886744-26-000032 |
| Q1 2025Quarterly · 2025-03-31 | Product | Royalty | 167,000 | USD | 0000886744-26-000032 |
| Q1 2025Quarterly · 2025-03-31 | Product | Sales Returns And Allowance | -113,000 | USD | 0000886744-26-000032 |
| Q3 2024Quarterly · 2024-09-30 | Product | Chargebacks And Customer Credits | -4,002,000 | USD | 0000886744-25-000071 |
| Q3 2024Quarterly · 2024-09-30 | Product | Government Rebates | -364,000 | USD | 0000886744-25-000071 |
| Q3 2024Quarterly · 2024-09-30 | Product | Revenues Before Adjustments | 32,657,000 | USD | 0000886744-25-000071 |
| Q3 2024Quarterly · 2024-09-30 | Product | Royalty | 62,000 | USD | 0000886744-25-000071 |
| Q3 2024Quarterly · 2024-09-30 | Product | Sales Returns And Allowance | -82,000 | USD | 0000886744-25-000071 |
| Q2 2024Quarterly · 2024-06-30 | Product | Chargebacks And Customer Credits | -97,000 | USD | 0000886744-25-000052 |
| Q2 2024Quarterly · 2024-06-30 | Product | Government Rebates | -11,000 | USD | 0000886744-25-000052 |
| Q2 2024Quarterly · 2024-06-30 | Product | Revenues Before Adjustments | 890,000 | USD | 0000886744-25-000052 |
| Q2 2024Quarterly · 2024-06-30 | Product | Royalty | 102,000 | USD | 0000886744-25-000052 |
| Q2 2024Quarterly · 2024-06-30 | Product | Sales Returns And Allowance | -2,000 | USD | 0000886744-25-000052 |
| Q1 2024Quarterly · 2024-03-31 | Product | Chargebacks And Customer Credits | 0 | USD | 0000886744-25-000010 |
| Q1 2024Quarterly · 2024-03-31 | Product | Government Rebates | 0 | USD | 0000886744-25-000010 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product | 0 | USD | 0000886744-25-000010 |
| Q1 2024Quarterly · 2024-03-31 | Product | Revenues Before Adjustments | 0 | USD | 0000886744-25-000010 |
| Q1 2024Quarterly · 2024-03-31 | Product | Royalty | 304,000 | USD | 0000886744-25-000010 |
| Q1 2024Quarterly · 2024-03-31 | Product | Sales Returns And Allowance | 0 | USD | 0000886744-25-000010 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.